Spinal Cord Injury — Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury
Citation(s)
Bernard PL, Mercier J, Varray A, Prefaut C Influence of lesion level on the cardioventilatory adaptations in paraplegic wheelchair athletes during muscular exercise. Spinal Cord. 2000 Jan;38(1):16-25. doi: 10.1038/sj.sc.3100956.
Claydon VE, Krassioukov AV Orthostatic hypotension and autonomic pathways after spinal cord injury. J Neurotrauma. 2006 Dec;23(12):1713-25. doi: 10.1089/neu.2006.23.1713.
Claydon VE, Steeves JD, Krassioukov A Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord. 2006 Jun;44(6):341-51. doi: 10.1038/sj.sc.3101855. Epub 2005 Nov 22.
De Troyer A, Estenne M, Heilporn A Mechanism of active expiration in tetraplegic subjects. N Engl J Med. 1986 Mar 20;314(12):740-4. doi: 10.1056/NEJM198603203141203.
DeVivo MJ, Krause JS, Lammertse DP Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9. doi: 10.1016/s0003-9993(99)90252-6.
Krassioukov A Autonomic function following cervical spinal cord injury. Respir Physiol Neurobiol. 2009 Nov 30;169(2):157-64. doi: 10.1016/j.resp.2009.08.003. Epub 2009 Aug 12.
Teasell RW, Arnold JM, Krassioukov A, Delaney GA Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000 Apr;81(4):506-16. doi: 10.1053/mr.2000.3848.
Walter JS, Sacks J, Othman R, Rankin AZ, Nemchausky B, Chintam R, Wheeler JS A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management. J Rehabil Res Dev. 2002 Jan-Feb;39(1):53-61. Erratum In: J Rehabil Res Dev. 2002 Sep-Oct;39(5):623.
Winslow C, Rozovsky J Effect of spinal cord injury on the respiratory system. Am J Phys Med Rehabil. 2003 Oct;82(10):803-14. doi: 10.1097/01.PHM.0000078184.08835.01.
Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
